You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 9 No. 1, Jan-Feb 2007 TABLE OF CONTENTS
  Archives
  •  Online Features
  Brief Communication
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Facial Plastic Surgery
 •Biomaterials and Implants
 •Trauma/ Maxillofacial Surgery
 •Alert me on articles by topic

Injectable Calcium Hydroxyapatite Filler for Minimally Invasive Delayed Treatment of Traumatic Enophthalmos

Reem Z. Renno, MD

Arch Facial Plast Surg. 2007;9(1):62-63.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

INTRODUCTION

Enophthalmos of 2 mm or more is aesthetically unacceptable and usually requires surgical intervention. For complex orbitofacial fractures with ocular retrusion, combined modalities such as reduction of the herniated content, osteotomy, fixation of fracture, and placement of onlay graft to support the orbital structures and to correct enophthalmos are usually necessary.1 However, in cases in which loss of volume is not associated with fracture, volume augmentation alone can be performed through placement of autogenous tissues and alloplastic materials such as blocks, sheets, beads, and injectable forms.2-8

Radiesse (BioForm Medical Inc, San Mateo, Calif) is an injectable implant consisting of small particles of calcium hydroxylapatite (microspheres 25-45 µm in diameter) suspended in an aqueous gel carrier. It has been used for years for vocal cord and bladder dysfunction and has a long-lasting effect (1-11/2 years). It has also been used for soft tissue augmentation as part of . . . [Full Text of this Article]

REPORT OF A CASE

COMMENT

AUTHOR INFORMATION







HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2007 American Medical Association. All Rights Reserved.